![Jennifer Creel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Jennifer Creel worked as Vice President-Global Finance & Business Planning at Celgene Corp.
from 2008 to 2020.
She then worked as Chief Financial Officer at ADC Therapeutics SA from 2020 to 2022.
Ms. Creel received an undergraduate degree from The College of William & Mary and an MBA from the University of Virginia Darden School of Business.
Antiguos cargos conocidos de Jennifer Creel.
| Empresas | Cargo | Fin |
|---|---|---|
| ADC THERAPEUTICS SA | Director Financiero/CFO | 19/12/2022 |
| CELGENE | Corporate Officer/Principal | 01/01/2020 |
Formación de Jennifer Creel.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
80
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Jennifer Creel
